docarpamine has been researched along with Heart Failure in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiba, S; Fuse, S; Tomita, H | 1 |
| Casagrande, C; La Regina, A; Merlo, L | 1 |
| Hara, M; Kawamura, K; Kino, M; Kubo, S; Kubota, J; Nakayama, A; Nishimura, H; Ueyama, M | 1 |
| Casagrande, C; Ferrini, R; Merlo, L; Miragoli, G; Semeraro, C | 1 |
2 review(s) available for docarpamine and Heart Failure
| Article | Year |
|---|---|
Development of dopaminergic drugs for the chronic treatment of congestive heart failure.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Deoxyepinephrine; Dopamine; Dopamine Agents; Fenoldopam; Heart Failure; Humans; Levodopa; Receptors, Dopamine | 1990 |
Cardiovascular and renal action of dopaminergic prodrugs.
Topics: Animals; Cardiotonic Agents; Cats; Chemical Phenomena; Chemistry; Deoxyepinephrine; Dihydroxyphenylalanine; Dogs; Dopamine; Dopamine Agents; Drug Design; Female; Heart Failure; Hemodynamics; Humans; Kidney; Levodopa; Male; Prodrugs; Rabbits; Rats; Vasodilator Agents | 1989 |
1 trial(s) available for docarpamine and Heart Failure
| Article | Year |
|---|---|
Plasma concentration and acute clinical effects of docarpamine, orally active dopamine prodrug, in infants.
Topics: Administration, Oral; Age Factors; Dopamine; Dopamine Agonists; Drug Monitoring; Heart Failure; Hemodynamics; Humans; Infant; Infant, Newborn; Prodrugs; Time Factors | 1996 |
1 other study(ies) available for docarpamine and Heart Failure
| Article | Year |
|---|---|
Cardiorenal effects of an orally active dopamine prodrug (TA-870) in patients with congestive heart failure.
Topics: Adult; Aged; Dopamine; Echocardiography; Electrolytes; Female; Glomerular Filtration Rate; Heart Failure; Heart Function Tests; Humans; Male; Middle Aged; Potassium; Prodrugs; Renal Circulation; Sodium; Vascular Resistance | 1989 |